COVI Special Committee - Exchange of views with the European Centre for Disease Prevention and Control (ECDC) and Health Emergency Preparedness and Response Authority (HERA) on COVID-19 pandemic

Special Committee on the COVID-19 pandemic: lessons learned and recommendations for the future

COVI Special Committee - Exchange of views with Stella Kyriakides, Commissioner for Health and Food Safety

COVI - Special Committee on COVID-19 pandemic : lessons learned and recommendations for the future

Kathleen VAN BREMPT (S&D ,BE), Chair and Dolors MONTSERRAT (EPP, ES) rapporteur, hold a press conference to present the results of the work of the Committee on collecting the evidence and lessons learned from the COVID-19 pandemic as well as to give answers on the impact it had on citizens and their fundamental rights, the businesses, the health sector and international community. The transcript is the result of an automated process. Please check against delivery.

Press conference by Kathleen VAN BREMPT (S&D ,BE), Chair and Dolors MONTSERRAT (EPP, ES), Rapporteur, on the Special Committee' report on lessons learned and recommendations for the future following the COVID-19 pandemic

The COVI Committee (Special Committee on the COVID-19 pandemic) votes on its final report, adopted by 23 votes in favour, 13 against and one abstention. Extracts from the vote and statements by Dolors MONTSERRAT (EPP,ES), Rapporteur and by Kathleen VAN BREMPT (S&D,BE), COVI Chair. The report which concludes the year and three months a half long intensive work of the Committee on collecting the evidence and lessons learned from the COVID-19 pandemic and the impact it had on citizens and their fundamental rights, the businesses, the health sector and international community.

COVID-19 pandemic: lessons learned and recommendations for the future: extracts from the vote (12/06) and statements by Dolors MONTSERRAT (EPP, ES), Rapporteur and by Kathleen VAN BREMPT (S&D, BE), COVI Chair

From 2020 to 2022, the European Union has faced a public health threat with the COVID-19 pandemic. On 10 March 2022, the European Parliament established a new special committee on the COVID-19 pandemic, composed of 38 members. After more than a year of work, the final report is voted and presents its recommendations for the future, based on the lesson learned. This clip illustrates two years of pandemic through footages of lockdowns, testings, masks distributions, vaccinations, digital certificates but also comes back on the work of the COVI Committee with extracts of past meetings.

Memoclip: COVID-19 pandemic - lessons learned and recommendations for the future

MEPs from the COVI Committee (Special Committee on the COVID-19 pandemic: lessons learned and recommendations for the future) exchange with Stella KYRIAKIDES, Commissioner for Health, Food and Safety Commissioner on new regulation on cross-border threats to health, a new EU network of reference laboratories, the long-Covid side effects and the transparency around vaccines contracts. In a second part, they exchange with Emer COOKE, Executive Director of the European Medicines Agency on the recommendations to strengthen EMA’s response to future public health emergencies. Extracts.

Exchange of views with Stella KYRIAKIDES, European Commissioner for Health and Food Safety and with Emer COOKE, Executive Director of the European Medicines Agency (EMA): extracts - COVI Committee

During a public hearing of the Special Committee on the COVID-19 pandemic, MEPs discuss about how to tackle misleading and false information, especially on social media, the impact of conspiracy theories on vaccine hesitancy, the role of online platforms and traditional media outlets in spreading awareness but also misinformation and disinformation around the pandemic. Extracts from the public hearing.

The impact of disinformation, misinformation and propaganda on democracy during the pandemic: extracts from the public hearing - EP Special Committee on the COVID-19 pandemic

Representatives from Pfizer and Curevac share their views on past and present manufacturing, distribution and equitable access of the COVID-19 vaccines and therapeutics. The debate focuses on the activities undertaken to develop vaccines for new variants, the authorisation process, and transparency of contracts. Extracts from the exchange of views with Janine Small, President of International Developed Markets, Pfizer and and Dr Franz-Werner Haas, Chief Executive Officer, Curevac.

COVID-19 - Lessons learned and recommendations for the future: extracts from the exchange of views - EP Special Committee on the COVID-19 pandemic

&lt;p>MEPS from the COVI Committee talk with representatives from pharmaceutical companies that worked on developing vaccines and therapeutics during the COVID-19 pandemic. Dr Rudolf Ertl, Senior Vice-President Commercial Operations (Gilead Sciences), Thomas Triomphe, Executive Vice-President of Vaccines (Sanofi), Iskra Reic, Executive Vice-President of Europe and Canada, (AstraZeneca) and Stéphane Bancel, Chief Executive Officer, (Moderna) participate to the debate.&lt;/p>

COVID-19 - debate with the pharmaceutical industry: extracts from the exchange of views with representatives from Gilead Sciences, Sanofi, AstraZeneca and Moderna

Special Committee’s on the COVID-19 pandemic holds an exchange of views with Sandra Gallina, Director-General for Health and Food Safety. MEPs discuss the main challenges that the EU and its Member States faced in handling the COVID-19 pandemic, the health issues, how Advanced Purchase Agreements were drawn up, and the lessons learned for the future. Kathleen VAN BREMPT (S&D,BE), COVI Chair and Kathleen VAN BREMPT (S&D,BE) issues a statement.

Special Committee COVID-19 pandemic: lessons learned and recommendations for the future

Videos

Bilder

Bildergalerien

Medien veröffentlicht für diese Markierung

9

Videos

3

Bildergalerien

85

Bilder